Using a Nebulizer

Nebulized PULMICORT RESPULES can help put asthma control within young patients’ reach

When a parent or caregiver is unfamiliar with using a nebulizer, he or she may have concerns. Educating them about the benefits of nebulization and providing nebulization tips may help.

Nebulization provides direct delivery to a child's lungs¹⁷
Patient coordination is not needed — the child just breathes through the nebulizer¹⁷
The average nebulization time in pivotal trials was 5 minutes (some jet nebulizers/compressors may take up to 10 minutes)²³

In this section

Nebulizer Basics
Help parents learn the difference between the two main types of nebulizers: jet nebulizers and ultrasonic nebulizers.¹⁷

Jet Nebulizers vs Other Devices
Educate parents on the benefits of jet nebulizers compared to other commonly used asthma devices.

Locate a Nebulizer
Find a list of online retailers that offer nebulizers and other asthma-related products.

Enlarge Text:

Print:

Educational resources for families in your care.

Links to learn about other asthma treatment options for patients:

Indication

PULMICORT RESPULES is indicated for the maintenance treatment of asthma and as prophylactic therapy in children ages 12 months to 8 years.

PULMICORT RESPULES is not a bronchodilator and is NOT indicated for the relief of acute bronchospasm.

Important Safety Information

Inhaled corticosteroids may cause a reduction in growth velocity. The long-term effect on final adult height is unknown.

PULMICORT RESPULES, like other inhaled corticosteroids, may impact the hypothalamic-pituitary-adrenal axis, especially in susceptible individuals, in young children, and in patients given high doses for prolonged periods.

Particular care is needed for patients who are transferred from systemically active corticosteroids to less systemically available corticosteroids, because deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids (see WARNINGS in full Prescribing Information).

Patients taking immunosuppressant doses of corticosteroids should avoid exposure to infections such as chicken pox and measles.

Common adverse events reported in clinical trials, regardless of relationship to treatment, included respiratory infection, rhinitis, coughing, otitis media, viral infection, gastroenteritis, ear infection, oral thrush/candidiasis, and epistaxis.

Please see accompanying full Prescribing Information (PDF).

Site Map | References | Contact Us